600143:SSEKingfa Sci. & Tech. Co., Ltd. Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥17.11
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Kingfa Sci. & Tech. is trading at ¥17.11, essentially at its calculated support level of ¥17.11, while the 20‑day SMA (¥18.44) and 50‑day SMA (¥19.19) sit well above the current price, indicating short‑term downside pressure. The RSI of 32.8 suggests the stock is approaching oversold conditions, yet the MACD histogram remains negative and the signal line is bearish, reinforcing a cautious technical outlook. Valuation metrics are stark: a trailing P/E of 36.4 versus a DCF‑derived fair value of ¥7.45 points to a significant premium, and the forward P/E of 22.9 still implies limited upside.
Fundamentally, revenue growth is modest at 5% with thin gross (10.9%) and operating margins (5.0%), while the company carries a heavy debt load (debt‑to‑equity ≈ 132) and generated negative free cash flow, raising concerns about financial resilience. The dividend yield of 0.57% and a modest payout ratio of 21% look sustainable on paper, but the weak cash conversion and high leverage cast doubt on long‑term dividend reliability. Combined with high 30‑day volatility (≈31%) and a low beta, the stock presents a mixed risk profile despite the market’s “Extreme Greed” sentiment.
Fundamentally, revenue growth is modest at 5% with thin gross (10.9%) and operating margins (5.0%), while the company carries a heavy debt load (debt‑to‑equity ≈ 132) and generated negative free cash flow, raising concerns about financial resilience. The dividend yield of 0.57% and a modest payout ratio of 21% look sustainable on paper, but the weak cash conversion and high leverage cast doubt on long‑term dividend reliability. Combined with high 30‑day volatility (≈31%) and a low beta, the stock presents a mixed risk profile despite the market’s “Extreme Greed” sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is at technical support with limited upside
- RSI near oversold but MACD remains bearish
- Decreasing volume suggests weakening buying interest
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation relative to DCF fair value
- High leverage and negative free cash flow
- Bearish MACD and lack of earnings acceleration
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Sustained debt burden limits strategic flexibility
- Margins remain thin in a competitive specialty chemicals sector
- Dividend sustainability is questionable given cash flow constraints
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin1.73%
P/E Ratio36.4
ROE2.67%
ROA1.93%
Debt/Equity131.78
P/B Ratio2.3
Op. Cash FlowCN¥3.7B
Free Cash FlowCN¥-713288896
Technical Analysis
TrendNeutral
RSI32.8
SupportCN¥17.11
ResistanceCN¥19.88
MA 20CN¥18.44
MA 50CN¥19.19
MA 200CN¥16.57
MACDBearish
VolumeDecreasing
Fear & Greed Index80.52
Valuation
Fair ValueCN¥7.45
GradeOvervalued
TypeBlend
Dividend Yield0.57%
Risk Assessment
Beta0.20
Volatility31.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.